|
OMIM |
Link |
Information gain |
01 |
|
DYTCA
|
[NCBI]
|
0.0010375
|
|
|
myopia 13
|
[NCBI]
|
0.0010375
|
|
|
retinitis pigmentosa 34
|
[NCBI]
|
0.0010375
|
|
|
DYX9
|
[NCBI]
|
0.000819746
|
|
|
RP6
|
[NCBI]
|
0.000684465
|
|
|
RP24
|
[NCBI]
|
0.000684465
|
|
|
RPGR
|
[NCBI]
|
0.000596153
|
|
|
MEAX
|
[NCBI]
|
0.000587372
|
|
|
PHP
|
[NCBI]
|
0.000587372
|
|
|
SHFM2
|
[NCBI]
|
0.000587372
|
|
|
HYPX
|
[NCBI]
|
0.000545541
|
|
|
CBBM
|
[NCBI]
|
0.000473781
|
|
|
BTHS
|
[NCBI]
|
0.000385177
|
|
|
coffin-siris syndrome
|
[NCBI]
|
0.000370394
|
|
|
GPS
|
[NCBI]
|
0.000354149
|
|
|
DYT3
|
[NCBI]
|
0.000294927
|
|
|
hypertelorism with esophageal abnormality and hypospadias
|
[NCBI]
|
0.000271087
|
|
|
RP3
|
[NCBI]
|
0.00025227
|
|
|
SCIDX1
|
[NCBI]
|
0.000222606
|
|
|
FLNA
|
[NCBI]
|
0.000221349
|
|
|
CACNA1F
|
[NCBI]
|
0.000213524
|
|
|
SLC16A2
|
[NCBI]
|
0.000210035
|
|
|
AHDS
|
[NCBI]
|
0.000202319
|
|
|
RA
|
[NCBI]
|
0.000201396
|
|
|
NHS
|
[NCBI]
|
0.000196775
|
|
|
mental retardation, x-linked, syndromic, jarid1c-related
|
[NCBI]
|
0.000177273
|
|
|
CFNS
|
[NCBI]
|
0.000175897
|
|
|
retinitis pigmentosa, x-linked, with recurrent respiratory infections
|
[NCBI]
|
0.000167686
|
|
|
RP
|
[NCBI]
|
0.000159244
|
|
|
MTM1
|
[NCBI]
|
0.000144789
|
|
|
RENS1
|
[NCBI]
|
0.000131897
|
|
|
heterotopia, periventricular, x-linked dominant
|
[NCBI]
|
0.000122621
|
|
|
CDLS2
|
[NCBI]
|
0.000111006
|
|
|
CSNB1A
|
[NCBI]
|
0.000110963
|
|
|
TBX22
|
[NCBI]
|
0.00010846
|
|
|
OKS
|
[NCBI]
|
0.000103546
|
|
|
MCOPS7
|
[NCBI]
|
0.000100404
|
|
|
TAF1
|
[NCBI]
|
9.90517e-05
|
|
|
SOX3
|
[NCBI]
|
9.90517e-05
|
|
|
SMAX1
|
[NCBI]
|
9.88741e-05
|
|
|
ZIC3
|
[NCBI]
|
9.67053e-05
|
|
|
TIMM8A
|
[NCBI]
|
9.4609e-05
|
|
|
tn syndrome
|
[NCBI]
|
8.85507e-05
|
|
|
SLC6A8
|
[NCBI]
|
8.79281e-05
|
|
|
BTK
|
[NCBI]
|
8.76285e-05
|
|
|
PQBP1
|
[NCBI]
|
8.52818e-05
|
|
|
ED1
|
[NCBI]
|
8.43982e-05
|
|
|
TAZ
|
[NCBI]
|
8.40813e-05
|
|
|
immunodeficiency without anhidrotic ectodermal dysplasia
|
[NCBI]
|
8.00857e-05
|
|
|
interleukin 2 receptor, alpha, deficiency of
|
[NCBI]
|
8.00857e-05
|
|
|
chromosome xp11.3 deletion syndrome
|
[NCBI]
|
8.00857e-05
|
|
|
CLS
|
[NCBI]
|
7.84698e-05
|
|
|
MTM1
|
[NCBI]
|
7.56835e-05
|
|
|
CMTX5
|
[NCBI]
|
7.45945e-05
|
|
|
CORDX3
|
[NCBI]
|
7.45945e-05
|
|
|
utp14, s. cerevisiae, homolog of, b
|
[NCBI]
|
7.31455e-05
|
|
|
C1GALT1C1
|
[NCBI]
|
7.31455e-05
|
|
|
immunodeficiency with hyper-igm, type 3
|
[NCBI]
|
7.05157e-05
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
6.87351e-05
|
|
|
hypogammaglobulinemia and isolated growth hormone deficiency, x-linked
|
[NCBI]
|
6.72687e-05
|
|
|
SH2D1A
|
[NCBI]
|
6.62457e-05
|
|
|
WAS
|
[NCBI]
|
6.53131e-05
|
|
|
RP2
|
[NCBI]
|
6.40403e-05
|
|
|
FOXP3
|
[NCBI]
|
6.36279e-05
|
|
|
intestinal pseudoobstruction, neuronal, chronic idiopathic, x-linked
|
[NCBI]
|
6.22648e-05
|
|
|
creatine deficiency syndrome, x-linked
|
[NCBI]
|
6.22648e-05
|
|
|
CSNB2A
|
[NCBI]
|
6.02503e-05
|
|
|
SMC1A
|
[NCBI]
|
5.93711e-05
|
|
|
UTP14A
|
[NCBI]
|
5.93711e-05
|
|
|
growth-mental deficiency syndrome of myhre
|
[NCBI]
|
5.84626e-05
|
|
|
opitz syndrome
|
[NCBI]
|
5.84626e-05
|
|
|
encephalopathy, neonatal severe, due to mecp2 mutations
|
[NCBI]
|
5.53973e-05
|
|
|
HTX1
|
[NCBI]
|
5.53973e-05
|
|
|
FTMT
|
[NCBI]
|
5.41759e-05
|
|
|
IL21R
|
[NCBI]
|
5.41759e-05
|
|
|
SEDT
|
[NCBI]
|
5.4062e-05
|
|
|
THC1
|
[NCBI]
|
5.4062e-05
|
|
|
phosphoglycerate kinase 1 deficiency
|
[NCBI]
|
5.28309e-05
|
|
|
CORDX1
|
[NCBI]
|
5.28309e-05
|
|
|
GJB1
|
[NCBI]
|
5.27255e-05
|
|
|
OPD1
|
[NCBI]
|
5.16892e-05
|
|
|
amelogenesis imperfecta, hypoplastic/hypomaturation, x-linked 1
|
[NCBI]
|
5.16892e-05
|
|
|
HCCS
|
[NCBI]
|
5.08044e-05
|
|
|
MTS
|
[NCBI]
|
5.06248e-05
|
|
|
OPD2
|
[NCBI]
|
4.96281e-05
|
|
|
infantile spasm syndrome, x-linked
|
[NCBI]
|
4.96281e-05
|
|
|
FMD
|
[NCBI]
|
4.86911e-05
|
|
|
JARID1C
|
[NCBI]
|
4.82989e-05
|
|
|
NYX
|
[NCBI]
|
4.82989e-05
|
|
|
MED12
|
[NCBI]
|
4.82989e-05
|
|
|
SUMO1
|
[NCBI]
|
4.82989e-05
|
|
|
NODAL
|
[NCBI]
|
4.82989e-05
|
|
|
AIED
|
[NCBI]
|
4.69708e-05
|
|
|
BFLS
|
[NCBI]
|
4.69708e-05
|
|
|
danon disease
|
[NCBI]
|
4.69708e-05
|
|
|
LDB3
|
[NCBI]
|
4.63036e-05
|
|
|
MNS
|
[NCBI]
|
4.4702e-05
|
|
|
NHS
|
[NCBI]
|
4.46454e-05
|
|
|
FSCN2
|
[NCBI]
|
4.46454e-05
|
|
|
CPX
|
[NCBI]
|
4.40141e-05
|
|
|
MID1
|
[NCBI]
|
4.32267e-05
|
|
|
EFNB1
|
[NCBI]
|
4.19872e-05
|
|
|
CD40
|
[NCBI]
|
4.19872e-05
|
|
|
CDKL5
|
[NCBI]
|
4.08867e-05
|
|
|
LAMP2
|
[NCBI]
|
4.08867e-05
|
|
|
HSAS
|
[NCBI]
|
3.94011e-05
|
|
|
DCX
|
[NCBI]
|
3.89986e-05
|
|
|
LMO2
|
[NCBI]
|
3.81756e-05
|
|
|
MDLS
|
[NCBI]
|
3.75316e-05
|
|
|
CMTX1
|
[NCBI]
|
3.75316e-05
|
|
|
AMELX
|
[NCBI]
|
3.74164e-05
|
|
|
XLP1
|
[NCBI]
|
3.66774e-05
|
|
|
GK
|
[NCBI]
|
3.60552e-05
|
|
|
EBP
|
[NCBI]
|
3.60552e-05
|
|
|
ATS
|
[NCBI]
|
3.4734e-05
|
|
|
CLCN5
|
[NCBI]
|
3.37976e-05
|
|
|
EDA
|
[NCBI]
|
3.37976e-05
|
|
|
IL2RG
|
[NCBI]
|
3.33067e-05
|
|
|
CD40LG
|
[NCBI]
|
3.11683e-05
|
|
|
IKBKG
|
[NCBI]
|
3.00814e-05
|
|
|
CYBB
|
[NCBI]
|
3.00814e-05
|
|
|
GAMT
|
[NCBI]
|
2.91053e-05
|
|
|
PHEX
|
[NCBI]
|
2.82198e-05
|
|
|
ND
|
[NCBI]
|
2.76629e-05
|
|
|
PGK1
|
[NCBI]
|
2.74098e-05
|
|
|
L1CAM
|
[NCBI]
|
2.74098e-05
|
|
|
RS1
|
[NCBI]
|
2.71545e-05
|
|
|
MAOA
|
[NCBI]
|
2.49221e-05
|
|
|
FGF23
|
[NCBI]
|
2.47255e-05
|
|
|
WAS
|
[NCBI]
|
2.4533e-05
|
|
|
IL4
|
[NCBI]
|
2.31216e-05
|
|
|
APS1
|
[NCBI]
|
2.1351e-05
|
|
|
CDLS1
|
[NCBI]
|
1.96559e-05
|
|
|
TNF
|
[NCBI]
|
1.95728e-05
|
|
|
RHO
|
[NCBI]
|
1.82895e-05
|
|
|
IP
|
[NCBI]
|
1.74307e-05
|
|
|
MECP2
|
[NCBI]
|
1.57407e-05
|
|
|
PCD
|
[NCBI]
|
1.4487e-05
|
|
|
AIS
|
[NCBI]
|
1.38767e-05
|
|
|
FMR1
|
[NCBI]
|
1.2546e-05
|
|
|
SOD2
|
[NCBI]
|
6.6205e-06
|
|
|
CVID
|
[NCBI]
|
6.05633e-06
|
|
|
ALD
|
[NCBI]
|
3.96678e-06
|
|
|
G6PD
|
[NCBI]
|
8.60861e-07
|
|
|
AR
|
[NCBI]
|
1.03375e-07
|
|